Patents by Inventor Andrew J. RENNEKAMP

Andrew J. RENNEKAMP has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEUROACTIVE COMPOUNDS AND METHODS OF USING SAME
    Publication number: 20190337956
    Abstract: The invention described herein relates generally to neuroactive compounds and compositions for the treatment psychotic disorders, methods for treating psychosis using these neuroactive compounds, and methods for screening for novel neuroactive compounds. Certain aspects are directed to a family of compounds called “finazines.” Certain aspects are directed to in vivo screening methods using high-throughput behavioral assays in zebrafish.
    Type: Application
    Filed: April 9, 2019
    Publication date: November 7, 2019
    Applicant: The General Hospita Corporation
    Inventors: Randall T. Peterson, Andrew J. Rennekamp, David Kokel, You Wang
  • Neuroactive compounds and methods of using the same
    Patent number: 10301318
    Abstract: The invention described herein relates generally to neuroactive compounds and compositions for the treatment psychotic disorders, methods for treating psychosis using these neuroactive compounds, and methods for screening for novel neuroactive compounds. Certain aspects are directed to a family of compounds called “finazines.” Certain aspects are directed to in vivo screening methods using high-through-put behavioral assays in zebrafish.
    Type: Grant
    Filed: June 25, 2015
    Date of Patent: May 28, 2019
    Assignee: The General Hospital Corporation
    Inventors: Randall T. Peterson, Andrew J. Rennekamp, David Kokel, You Wang
  • NEUROACTIVE COMPOUNDS AND METHODS OF USING THE SAME
    Publication number: 20170247383
    Abstract: The invention described herein relates generally to neuroactive compounds and compositions for the treatment psychotic disorders, methods for treating psychosis using these neuroactive compounds, and methods for screening for novel neuroactive compounds. Certain aspects are directed to a family of compounds called “finazines.” Certain aspects are directed to in vivo screening methods using high-through-put behavioral assays in zebrafish.
    Type: Application
    Filed: June 25, 2015
    Publication date: August 31, 2017
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Randall T. PETERSON, Andrew J. RENNEKAMP, David KOKEL, You WANG